NewAmsterdam Pharma Company
NAMS
#3911
Rank
A$4.96 B
Marketcap
A$42.44
Share price
-2.98%
Change (1 day)
18.14%
Change (1 year)

Earnings for NewAmsterdam Pharma Company (NAMS)

Earnings in 2026 (TTM): -A$0.33 Billion

According to NewAmsterdam Pharma Company's latest financial reports the company's current earnings are A$22.56 Million. In 2025 the company made an earning of -A$0.33 Billion, an increase over its 2024 earnings that were of -A$0.36 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for NewAmsterdam Pharma Company from 2023 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.33 Billion-0.83%
2025 -A$0.33 Billion-7.81%
2024 -A$0.36 Billion38.38%
2023 -A$0.26 Billion